BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21781259)

  • 1. Management of acquired haemophilia A.
    Collins PW
    J Thromb Haemost; 2011 Jul; 9 Suppl 1():226-35. PubMed ID: 21781259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acquired haemophilia A].
    Smejkal P; Buliková A; Chlupová G; Zavřelová J
    Vnitr Lek; 2012; 58(7-8):571-8. PubMed ID: 23067181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the understanding of acquired haemophilia A: implications for clinical practice.
    Collins PW; Percy CL
    Br J Haematol; 2010 Jan; 148(2):183-94. PubMed ID: 19814739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry.
    Tengborn L; Baudo F; Huth-Kühne A; Knoebl P; Lévesque H; Marco P; Pellegrini F; Nemes L; Collins P;
    BJOG; 2012 Nov; 119(12):1529-37. PubMed ID: 22901076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired haemophilia: an overview for clinical practice.
    Kessler CM; Knöbl P
    Eur J Haematol; 2015 Dec; 95 Suppl 81():36-44. PubMed ID: 26679396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired Hemophilia A: A Case Report.
    Shen M; Wang S; Sessa J; Hanna A; Axelrad A; Ali F
    J Pharm Pract; 2020 Aug; 33(4):562-566. PubMed ID: 30727803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of acquired haemophilia A.
    Tiede A; Scharf RE; Dobbelstein C; Werwitzke S
    Hamostaseologie; 2015; 35(4):311-8. PubMed ID: 25564260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors.
    Matino D; Makris M; Dwan K; D'Amico R; Iorio A
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD004449. PubMed ID: 26677005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired haemophilia: experiences with a standardized approach.
    Grünewald M; Beneke H; Güthner C; Germowitz A; Brommer A; Griesshammer M
    Haemophilia; 2001 Mar; 7(2):164-9. PubMed ID: 11260276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant factor VIIa (eptacog alfa): a pharmacoeconomic review of its use in haemophilia in patients with inhibitors to clotting factors VIII or IX.
    Lyseng-Williamson KA; Plosker GL
    Pharmacoeconomics; 2007; 25(12):1007-29. PubMed ID: 18047387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies.
    Holme PA; Brosstad F; Tjønnfjord GE
    Haemophilia; 2005 Sep; 11(5):510-5. PubMed ID: 16128896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bypassing agent prophylaxis in people with hemophilia A or B with inhibitors.
    Chai-Adisaksopha C; Nevitt SJ; Simpson ML; Janbain M; Konkle BA
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011441. PubMed ID: 28944952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
    Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of acquired hemophilia A.
    Collins PW
    J Thromb Haemost; 2007 May; 5(5):893-900. PubMed ID: 17461924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acquired haemophilia (acquired factor VIII inhibitor)].
    Ceresetto JM; Duboscq C; Fondevila C; Tezanos Pinto M
    Medicina (B Aires); 2015; 75(4):231-8. PubMed ID: 26339881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired inhibitors.
    Cohen AJ; Kessler CM
    Baillieres Clin Haematol; 1996 Jun; 9(2):331-54. PubMed ID: 8800509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A low-dose rituximab regimen for first-line treatment of acquired haemophilia A.
    Hunt S; Robertson J; Conn J; Casey J; Royle J; Collins J; Hourigan M; Richmond J; Yang Wang T; Mills A; Mason J
    Eur J Haematol; 2022 Jan; 108(1):28-33. PubMed ID: 34528303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).
    Collins P; Baudo F; Knoebl P; Lévesque H; Nemes L; Pellegrini F; Marco P; Tengborn L; Huth-Kühne A;
    Blood; 2012 Jul; 120(1):47-55. PubMed ID: 22517903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired haemophilia syndrome: pathophysiology and therapy.
    Elezović I
    Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():64-8. PubMed ID: 20229686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.